Extensive Use of 3D Nonfluoroscopic Mapping Systems for Reducing Radiation Exposure during Catheter Ablation Procedures: An Analysis of 10 Years of Activity
Table 1
Clinical characteristics of the population of this study.
TOTAL
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
#
%
#
#
#
#
#
#
#
#
#
#
PROCEDURES
1145
100
110
119
102
117
122
125
108
104
114
124
AGE
Mean [years]
55.7
-
53.9
53.3
57.5
54.7
56.5
54.4
55.3
57.1
56.5
58.1
Standard deviation [years]
16.1
-
16.2
16.8
14.4
16.7
16.22
16.1
16.6
17.3
15.6
14.3
SEX
F
449
60.8
39
55
44
44
45
47
43
39
57
36
M
696
39.2
71
64
58
73
77
78
65
65
57
88
HEART DISEASE
None
551
48.1
61
61
47
63
58
61
53
42
59
46
Hypertensive
335
29.3
23
27
28
25
31
44
29
37
36
55
Valvular
74
6.5
8
15
12
5
10
5
2
6
3
8
Ischemic
85
7.4
10
6
8
11
7
4
9
14
11
5
Dilated cardiomyopathy
54
4.7
6
5
4
8
12
3
8
1
1
6
Congenital
14
1.2
0
5
2
1
0
1
2
1
1
1
Other
32
2.8
2
0
1
4
4
7
5
3
3
3
LVEF
< 35%
46
4.0
6
1
5
5
5
2
8
5
3
6
> 55%
917
80.1
89
85
78
97
97
106
77
88
97
103
35-45%
42
3.7
5
5
4
7
8
2
4
2
3
2
45-55%
140
12.2
10
28
15
8
12
15
19
9
11
13
ARRHYTHMIA
AF
378
33.0
35
29
27
39
48
50
34
36
34
46
SVT
435
38.0
49
54
46
46
33
48
39
31
45
44
AFL/AT
244
21.3
25
32
24
18
27
23
22
27
21
25
VT
88
7.7
1
4
5
14
14
4
13
10
14
9
F, female; M, male; LVEF, left ventricular ejection fraction; AF, atrial fibrillation; SVT, supraventricular tachycardia; AFL, atrial flutter; AT, atrial tachycardia; VT, ventricular tachycardia
